Please wait a minute...
图/表 详细信息
医院获得性细菌性脑膜炎患者预后不良的危险因素分析及列线图预测模型的构建
杨梅, 廖啟安, 谭全会, 李婷婷, 张毅, 陈洁, 汤正好
诊断学理论与实践    2025, 24 (04): 441-448.   DOI:10.16150/j.1671-2870.2025.04.011
摘要   (27 HTML2 PDF(pc) (719KB)(4)  

目的:探讨医院获得性细菌性脑膜炎(hospital-acquired bacterial meningitis, HABM)患者预后不良的危险因素,并构建预测其发生的列线图模型。方法:连续纳入上海交通大学医学院附属第六人民医院2013年1月至2020年12月收治的110例医院获得性细菌性脑膜炎患者,根据出院时是否死亡将其分为死亡组(n=22)和生存组(n=88),同时随机将110例患者分为建模组(n=77)和验证组(n=33)。应用最小绝对收缩和选择算子(least absolute shrinkage and selection operator,LASSO)回归及多因素Logistic回归筛选HABM患者预后不良的危险因素,并基于危险因素构建列线图模型,采用受试者操作特征(receiver operating characteristic curve,ROC)曲线的曲线下面积(area under curve,AUC)评估模型区分度,用校准曲线评估模型内部一致性情况。结果:基于LASSO回归共筛选出脑脊液(cerebro-spinal fluid,CSF)微生物培养革兰染色阳性、血常规中性粒细胞计数升高、降钙素原升高、CSF蛋白含量升高、凝血酶原时间缩短、血培养阳性、腰池引流史这7个因素,建立了HABM预后不良列线图预测模型,建模组及验证组ROC曲线的AUC分别为0.931、0.862,校准图显示校准曲线与理想曲线吻合较好,具有良好的拟合优度。结论:本研究构建危险因素列线图模型对住院HABM患者死亡具有较好的预测性、一致性和临床实用性,有助于临床医生对HABM患者预后不良的发生风险进行初步评估。


Characteristic Cohort P-value Characteristic Cohort P value
Training Cohort
(n=77)
Internal Test Cohort
(n=33)
Training Cohort
(n=77)
Internal Test Cohort
(n=33)
Age(years) 57 ± 12 55 ± 14 0.524 Extraspinal diversion(%) 0.431
Sex(%) 0.861 No 70 (90.9%) 32 (97.0%)
Female 27 (35.1%) 11 (33.3%) Yes 7 (9.1%) 1 (3.0%)
Male 50 (64.9%) 22 (66.7%) CSF leakage(%) 0.448
Gram stain of CSF
microbial
0.317 No 72 (93.5%) 29 (87.9%)
Negetive 25 (32.5%) 14 (42.4%) Yes 5 (6.5%) 4 (12.1%)
Positive 52 (67.5%) 19 (57.6%) V-P shunting(%) 0.043
CSF Chloride(mmol/L) 119 ± 18 119 ± 12 0.834 No 68 (88.3%) 24 (72.7%)
CSF Sugar(mmol/L) 3.55 ± 2.33 2.56 ± 1.64 0.013 Yes 9 (11.7%) 9 (27.3%)
CSF protein(mmol/L) 5.0 ± 13.7 3.3 ± 3.6 0.32 Diplopneumonia(%) 0.432
CSF RBC(%) 0.56 No 20 (26.0%) 11 (33.3%)
Little 42 (54.5%) 16 (48.5%) Yes 57 (74.0%) 22 (66.7%)
Many 35 (45.5%) 17 (51.5%) Deep vein cannulation(%) 0.159
CSF WBC(× 106/L) 0.896 No 20 (26.0%) 13 (39.4%)
<100 50 (64.9%) 21 (63.6%) Yes 57 (74.0%) 20 (60.6%)
>100 27 (35.1%) 12 (36.4%) WBC(× 109/L) 13.1 ± 6.6 10.5 ± 5.3 0.033
Admission GCS 9.1 ± 3.8 8.9 ± 3.7 0.786 Neutrophil(× 109/L) 12.2 ± 16.2 8.3 ± 4.6 0.053
Blood culture(%) 0.281 Neutrophil percentage(%) 78 ± 10 78 ± 7 0.626
Negetive 61 (79.2%) 23 (69.7%) Monocytes(× 109/L) 0.84 ± 0.54 0.71 ± 0.43 0.175
Positive 16 (20.8%) 10 (30.3%) Lymphocytes(× 109/L) 1.27 ± 0.59 1.27 ± 0.59 0.998
More than two surge-ries(%) 0.159 PLT(× 109/L) 243 ± 117 240± 120 0.164
No 57 (74.0%) 20 (60.6%) Plateletcrit(%) 0.26 ± 0.12 0.30 ± 0.15 0.876
Yes 20 (26.0%) 13 (39.4%) Albumin to globulin ratio 11.39 ± 1.6 10.59 ± 1.15 0.335
GCS on the day of culture 8.9 ± 3.5 9.2 ± 3.5 0.723 CRP(mg/L) 81 ± 41 82 ± 23 0.445
Surgical incision length greater than 10 cm(%) 0.692 Procalcitonin(ng/mL) 0.92 ± 0.8 1.2 ± 0.9 0.126
No 52 (67.5%) 21 (63.6%) Average platelet volume(fL) 10.82 ± 1.24 10.41 ± 1.26 0.118
Yes 25 (32.5%) 12 (36.4%) Platelet mean width(fL) 13.23 ± 2.84 15.96 ± 17.91 0.391
Surgical time greater than 4 h 0.7 RBC(× 1012/L) 3.66 ± 0.85 3.48 ± 0.57 0.205
No(%) 63 (81.8%) 28 (84.8%) Albumin (g/L) 35.5 ± 4.9 36.2 ± 5.3 0.534
Yes 14 (18.2%) 5 (15.2%) Fibrinogen(g/L) 4.09 ± 2.17 3.77 ± 1.68 0.405
Tracheal intubation/
incision greater than 7 days(%)
0.793 APPT(s) 30 ± 10 31 ± 10 0.669
No 26 (33.8%) 12 (36.4%) INR 1.23 ± 1.14 1.11 ± 0.15 0.376
Yes 51 (66.2%) 21 (63.6%) Prothrombin time(s) 12.59 ± 1.65 12.78 ± 1.74 0.596
Fever(%) 0.823 D-D(mg/L) 4.2 ± 4.3 4.1 ± 3.7 0.908
No 25 (32.5%) 10 (30.3%) PT(s) 16.24 ± 1.72 16.80 ± 2.36 0.228
Yes 52 (67.5%) 23 (69.7%) FDP(mg/L) 13 ± 12 14 ± 10 0.91
External ventricular drainage greater than 7 days(%) >0.999 Antithrombin Ⅲ
activity(%)
86 ± 19 80 ± 23 0.226
No 42 (54.5%) 18 (54.5%) Proealeitonin(ng/mL) 275 ± 119 252 ± 105 0.332
Yes 35 (45.5%) 15 (45.5%)
View table in article
表2 建模组与验证组患者临床资料比较
本文的其它图/表